Related Experiment Video
Updated: Mar 31, 2026
10:30
A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
5.8K
Botulinum Neurotoxin Type A in Neurology: Update
Marco Orsini1, Marco Antonio Araujo Leite2, Tae Mo Chung3
1Centro Universitário Augusto Motta, Bonsucesso , Rio de Janeiro, Brasil ; Universidade Federal Fluminense, Departamento de Neurologia, Niterói , Rio de Janeiro, Brasil.
Neurology International
|October 22, 2015
Summary
Botulinum neurotoxin type A is a safe and effective treatment for neurological disorders involving muscle overactivity. It offers relief for conditions like dystonia, spasticity, and headache, with a proven safety record.
Area of Science:
- Neurology
- Neuroscience
- Pharmacology
Background:
- Botulinum neurotoxin type A targets the neuromuscular junction, making it suitable for muscle overactivity disorders.
- Seven serotypes exist, with types A and B clinically available for treating central nervous system (CNS) conditions.
Purpose of the Study:
- To review the current neurological applications of botulinum neurotoxin type A.
- To highlight its efficacy and safety in treating various CNS disorders characterized by muscle hyperactivity.
Main Methods:
- Review of existing literature on botulinum neurotoxin type A.
- Analysis of clinical data regarding its use in neurological conditions.
- Examination of the toxin's mechanism of action at molecular and physiological levels.
Main Results:
- Botulinum neurotoxin A is safe and effective for dystonia, spasticity, headache, and other CNS disorders.
- The toxin inhibits acetylcholine release at neuromuscular and autonomic cholinergic nerve terminals, and affects pain neurotransmitters.
- Effects are dose-dependent, transient, localized, and non-destructive, allowing individualized treatment.
Conclusions:
- Botulinum neurotoxin A is a valuable therapeutic agent for neurological conditions involving muscle hyperactivity.
- Its applications extend beyond muscle overactivity to autonomic dysfunction and sialorrhea.
- With over 20 years of human use, it has an established safety profile and provides relief for many patients.
Related Concept Videos
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.4K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.4K
01:26Chemical Synapses
12.4K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
12.4K
01:26Chemical Synapses
8.7K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.7K
01:29Neuromuscular Junction And Blockade
6.1K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
6.1K
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
1.2K
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
1.2K
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
1.8K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.8K